AzTrials
AzTrials

Postbiotics SupplementationPostBioExInNCT06428656

Postbiotics Supplementation, Gut Microbiota Composition, and Exercise-induced Inflammation

A study testing Postbiotics supplementation in people with Postbiotics Supplementation, run by University of Thessaly at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will investigate the effect of postbiotics supplementation on gut microbiota (GM) composition, exercise-induced oxidative stress and performance following eccentrically biased exercise. The study will be a cross-over, randomized, double-blind, controlled study that will be conducted in two cycles. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Postbiotics Supplementation
What is being tested?
Postbiotics supplementation
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteGreece
Study dates
1 Jun 2024to 30 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Physically active subjects (VO2max ≥35ml/kg/min)
  • Absence of musculoskeletal injury (≥6 months)
  • Abstinence from the use of ergogenic supplements (≥1 month)
  • Abstinence from anti-inflammatory drugs (≥1 month)
  • Abstinence from pre-pro-postbiotic supplements (≥6 months)
  • Abstinence from participating in exercise with eccentric content for at least 7 days before exercise
  • Abstinence from alcohol and energy drinks before exercise

Who cannot join

  • Recent history of musculoskeletal injury (<6 months)
  • Use of ergogenic performance supplements (<1 month)
  • Taking anti-inflammatory drugs (<1 month)
  • Taking pre-pro-postbiotic supplements (<6 months)
  • Participation in exercise with eccentric content in the previous 7 days before exercise
  • Consumption of alcohol and energy drinks before exercise

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Department of Physical Education and Sport Science, Uninersity of Thessaly

    Trikala, Thessaly, 42100

Other trials in Greece

About this study

Official title: The Effect of Postbiotics Supplementation on Gut Microbiota Composition and Exercise-induced Inflammation

This study will investigate the effect of postbiotics supplementation on gut microbiota (GM) composition, exercise-induced oxidative stress and performance following eccentrically biased exercise. The study will be a cross-over, randomized, double-blind, controlled study that will be conducted in two cycles. Participants will be randomly assigned into one of the two trials: i) Postbiotics supplementation for 4 weeks, ii) Placebo supplementation for 4 weeks. Participants will then perform a 45-min treadmill running at (-15% slope, ~70% VO2max) followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before, as well as 24 h, 48 h and 72 h following exercise, assessment of GM composition and metabolites (short-chain fatty acids), exercise induced muscle damage (EIMD) (delayed onset of muscle soreness, creatine kinase), complete blood count (CBC), blood inflammatory status (tumor necrosis factor alpha, interleukin 6, C-reactive protein), gut inflammatory status (lipopolysacharides-binding protein, zonulin), blood redox status (total antioxidant capacity, catalase, protein carbonyls, reduced glutathione, oxidized glutathione, and performance (knee-extensors' and knee-flexors' isometric, concentric, eccentric torque, countermovement jump) will be performed. In addition, metabolism (lactic acid) will be assessed before and 4 min following exercise. Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, CBC, blood inflammatory status, blood redox status and performance at the same time-points. At the second cycle, the participants will repeat the above procedures under the remaining condition. Between conditions, there will be a 14-day washout period. The results of the research will provide important information for coaches and physically active individuals, regarding the effectiveness of postbiotics to favorably change the gut microbiota composition and alleviate gut inflammation, exercise-induced inflammation and oxidative stress, and improve performance after intense exercise.

Read the detailed description

Acute, vigorous and/or unaccustomed eccentric exercise can induce muscle injury and inflammatory reactions, and oxidative stress, but also reduced muscle performance. For this reason, many professional as well as amateur athletes, often consume nutritional supplements such as antioxidants, anticipating to reduce inflammation and oxidative stress after intense exercise.

The human gastrointestinal tract is inhabited by various microorganisms, called the gut microbiome (GM). GM, among other things, contributes to the normal functioning of the immune system, contributes to the production of short-chain fatty acids (SCFAs) and vitamin synthesis as well as the digestion and absorption of food, protects against enteropathogens and regulates inflammatory and redox responses. Recent evidence also suggests that GM may be involved in athletic performance. In contrast, disruption of GM composition (dysbiosis) is characterized by reduced diversity, reduced abundance of health-promoting bacteria, and increased abundance of gram-negative and other pathogenic bacteria and is associated with various metabolic diseases such as obesity, diabetes, and various forms of cancer, systemic inflammation, oxidative stress and reduced performance. Thus, the supplementation of several "biotics" has been emerged as a means to regulate the GM in favor of health-promoting bacteria.

Postbiotics is defined as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host". Evidence suggests that supplementation with postbiotics may regulate the GM, and consequently, strengthen the immune system, reduce intestinal permeability, improve antioxidant mechanisms, as well as accelerate recovery after exercise-induced inflammation, enhance adaptations to exercise, and improve performance. However, the scientific data regarding the possible beneficial effect of supplemental administration of postbiotics is limited. More research is needed, in order to determine the role of postbiotics supplementation on GM composition and function, exercise-induced inflammation and redox status, but also on performance after intense exercise.

This study will investigate the potential of postbiotics supplementation to alter the GM composition and affect the recovery of exercise-induced oxidative stress and performance following intense, eccentrically biased acute exercise. The study will be cross-over, randomized, double-blind, controlled, and will be conducted in two cycles. The participants, will be primarily informed regarding the study procedures, as well as the benefits and possible risks, and will sign an informed consent form for participation in the study. Before the experimental procedure, they will be involved in a week of familiarization to the evaluation tests and the exercise protocol, at a low intensity. Participants will undergo baseline measurements: anthropometric characteristics (body height, body mass, body mass index) via a stadiometer-scale (Stadiometer 208; Seca, Birmingham, UK), body composition (amount of body fat, lean body mass, fat mass, bone density) via by dual emission X-ray absorptiometry (DXA, GE-Healthcare, Lunar DPX NT, Belgium), aerobic capacity (VO2max) via an automated online pulmonary gas analyzer (Vmax Encore 29, BEBJO296, Yorba Linda, CA, USA) during a graded exercise protocol on a treadmill (Stex 8025T, Korea), isokinetic strength (isometric, concentric and eccentric torque of the knee extensors and knee flexors) on an isokinetic dynamometer (Cybex, HUMAC NORM 360, Ronkonkoma, NY), and muscle power via the assessment of countermovement jump (CMJ) via an optical measurement system (Optojump next, Microgate, USA). In addition, the participants will record their diet via a 7-days recall before their participation in the first experimental condition, and dietary data will be analyzed with ScienceFit Diet 200A diet analysis program (Science Technologies, Athens, Greece), in order to estimate that they do not consume nutrients that may affect muscle injury, inflammation and oxidative stress (e.g. antioxidants, etc.). Participants will then be randomized in one of the two conditions: i) Postbiotics supplementation (50mg/day of Heatkilled Lactobacillus plantarum L-137, Immuno-LP20TM) for 4 weeks, or ii) placebo supplementation for 4 weeks. Randomization of the conditions will be done by a software generating random integers available on the internet (Random.org). Participants will then perform an exercise protocol comprised of 45 min downhill running (-15% slope, ~70-75% VO2max) on a treadmill followed by a time-trial (0% slope, ~95% VO2max) until exhaustion. Before the exercise protocol, as well as 24 h, 48 h and 72 h after exercise, exercise-induced muscle damage (EIMD) [delayed onset of muscle soreness (DOMS) via palpation of the knee extensors and knee flexors on a scale of 1 to 10 (1 = no pain at all; 10 = extreme pain), and muscle performance (CMJ, isometric, concentric and eccentric torque of the knee extensors and knee flexors)], will be assessed. At the same time points, feces samples will be collected for the analysis of GM composition and function, and GM metabolites, as well as blood samples for the assessment of complete blood count (CBC), blood inflammatory status (creatine kinase, tumor necrosis factor alpha, interleukin 6, C-reactive protein), gut inflammatory status (lipopolysacharides-binding protein, zonulin), and blood redox status [reduced glutathione (GSH), oxidized glutathione (GSSG), GSH/GSSG ratio, total antioxidant capacity, catalase, protein carbonyls, uric acid, bilirubin). Furthermore, metabolism (lactic acid) will be assessed before and 4 min following exercise by analyzing capillary blood with a portable lactate analyzer (Lactate Plus, Nova Biomedical, USA). Afterwards, the participants will receive the postbiotics supplement or the placebo for 4 weeks, and will repeat the exercise protocol and measurements of EIMD, CBC, blood inflammatory status, blood redox status and performance at the same time-points. At the second cycle, participants will repeat the exact same procedures for the remaining condition. Between cycles, a 14-days washout period will be applied. Additionally, the 7-day diet recall from the first cycle, will be given to the participants to follow the same diet before the experimental exercise protocol at the second cycle.

Being tested
Postbiotics supplementation, Placebo supplementation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Postbiotics supplementationDietary supplement

    The participants will consume one capsule of postbiotics supplement per day

  • Placebo supplementationDietary supplement

    The participants will consume one capsule of placebo per day

Study groups in NCT06428656
Study groupRoleWhat they receive
Postbiotics supplementationExperimentalSupplementation of postbiotics for 4 weeks
Receives: Dietary Supplement: Postbiotics supplementation
Placebo supplementationPlacebo comparatorSupplementation of placebo for 4 weeks
Receives: Dietary Supplement: Placebo supplementation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in gut microbiota composition

    Gut microbiota composition will be assessed in feces

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  2. Changes in butyrate

    Butyrate will be assessed in feces

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  3. Changes in propionate

    Propionate will be assessed in feces

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  4. Changes in acetate

    Acetate will be assessed in feces

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  5. Changes in complete blood count

    Complete blood count will be assessed in whole blood

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  6. Changes in creatine kinase activity

    Creatine kinase activity will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  7. Changes in TNF-α concentration

    TNF-α concentration will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  8. Changes in IL-6 concentration

    IL-6 concentration will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  9. Changes in high-sensitivity C-reactive protein concentration

    C-reactive protein concentration will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  10. Changes in lipopolysacharides-binding protein concentration

    Lipopolysacharides-binding protein concentration will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  11. Changes in zonulin concentration

    Zonulin concentration will be assessed in serum and in feces

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  12. Changes in protein carbonyls concentration

    Protein carbonyls concentration will be assessed in plasma

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  13. Changes in malondialdehyde concentration

    Malondialdehyde concentration will be assessed in plasma

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  14. Changes in reduced glutathione concentration

    Glutathione concentration will be assessed in red blood cells lycate

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  15. Changes in oxidized glutathione concentration

    Oxidized glutathione concentration will be assessed in red blood cells lycate

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  16. Changes in GSH/GSSG ratio

    GSH/GSSG ratio will be assessed in red blood cells lycate

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  17. Changes in catalase concentration

    Catalase concentration will be assessed in red blood cells lycate

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  18. Changes in total antioxidant capacity

    Total antioxidant capacity will be assessed in red blood cells lycate

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  19. Changes in uric acid concentration

    Uric acid concentration will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  20. Changes in bilirubin concentration

    Bilirubin concentration will be assessed in serum

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  21. Changes in blood lactate concentration

    Bilirubin concentration will be assessed in whole blood

    Measured: At baseline (pre), 4 min post-exercise

  22. Changes in delayed onset of muscle soreness in the knee flexors and extensors of both limbs

    Muscle soreness of the KF and KE will be assessed via palpation of the muscle belly and the distal regions following 3 squats, and the subjective pain will be recorded on a 10-point scale (1 = no pain, 10 = extreme pain)

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  23. Changes in countermovement jump height

    Countermovement jump height will be measured with an optical system

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

  24. Changes in isokinetic strength of knee extensors and knee flexors

    Isometric, concentric and eccentric peak torque of the knee extensors and knee flexors of both limbs will be assessed on an isokinetic dynamometer

    Measured: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2024
  2. Study start1 Jun 2024
  3. Primary completion30 Dec 2024
  4. Study completion30 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06428656
Sponsor's protocol ID
PB-GM-Exercise-Inflammation
Acronym
PostBioExIn
Status last verified
Feb 2026
First submitted
20 May 2024
Last updated
4 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Postbiotics supplementation in people with Postbiotics Supplementation, run by University of Thessaly at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in gut microbiota composition (time frame: At baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-exercise). The study lists 24 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in